11 Active TrialsLarge Center
2 MS centers statewide · Ranked #1 in District of Columbia for clinical trials · #1 in District of Columbia for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedPart of Major Health System
You are visiting an academic MS center with a strong specialty-care feel, backed by Georgetown University and MedStar Georgetown University Hospital. You can expect a multidisciplinary team, dedicated clinics, and helpful education and wellness programs. You should know this is a single-location center, so access is centered in Washington, DC.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care2/5
About Georgetown Multiple Sclerosis and Neuroimmunology Center
This center combines MS and neuroimmunology care with dedicated clinics for spasticity, neuromyelitis optica, and neuro-ophthalmology. It also stands out for its patient education and outreach programs, including Movement for MS and OWN MS.
Georgetown Multiple Sclerosis and Neuroimmunology Center cares for people with MS and other complex neuroimmunology conditions in Washington, DC. You can access specialty services for spasticity, neuromyelitis optica, and neuro-ophthalmology, along with testing such as visual field perimetry, OCT, and fundus photography. The center is part of Georgetown University and MedStar Georgetown University Hospital, and it holds NCQA Patient-Centered Specialty Practice recognition. Patients also benefit from education events, educational videos, and community programs like Movement for MS and OWN MS for newly diagnosed young adults.
Good to know
- Offers a dedicated Spasticity Clinic
- Offers a dedicated Neuromyelitis Optica Clinic
- Offers a dedicated Neuro-Ophthalmology Clinic
- Hosts Movement for MS classes over Zoom
- Provides outreach for newly diagnosed young adults with MS through OWN MS
Georgetown Multiple Sclerosis and Neuroimmunology Center is an academic MS center in Washington, DC, connected to Georgetown University and MedStar Georgetown University Hospital. You can expect care for multiple sclerosis and a range of related neuroimmunology conditions, including neuromyelitis optica, optic neuritis, and transverse myelitis. The center also holds NCQA Patient-Centered Specialty Practice recognition for organized, patient-centered care. In addition to medical visits, the team offers education programs, community outreach, and wellness activities.
Featured Care Team Members
Faria Amjad, MD
Assistant Professor, Department of Neurology; Director of Clinical Research, Georgetown Multiple Sclerosis and Neuroimmunology Center; Director, Spasticity Clinic
Brian Barry, MD
Fellow, Multiple Sclerosis and Neuroimmunology
Nancy Hu, MD
Assistant Professor, Department of Neurology; Core Team, Multiple Sclerosis Patient Centered Specialty Practice; Co-Director, Neurology Clerkship
Benjamin J. Osborne, MD
Associate Professor, Departments of Neurology and Ophthalmology; Director, Neuromyelitis Optica (NMO) Clinic
Robert K. Shin, MD
Professor, Department of Neurology; Director, Georgetown Multiple Sclerosis and Neuroimmunology Center
Susan Stuart, DNP, FNP-C, MSCN
Nurse Practitioner; Nursing Director, Georgetown Multiple Sclerosis and Neuroimmunology Patient-Centered Specialty Practice
Carlo Tornatore, MD
Professor and Chair, Department of Neurology; Executive Director, Multiple Sclerosis Patient Centered Specialty Practice
Faria Amjad, MD
Active MS Prescriber
Sumanjit Kaur, MD
Active MS Prescriber
Bethany Schreiber
Carlo Tornatore
Active MS Prescriber
Mitchell Wallin
Specialized Programs
Spasticity Clinic
Neuromyelitis Optica (NMO) Clinic
Neuro-Ophthalmology Clinic
Movement for MS
OWN MS (Outreach for Wellness in Newly-diagnosed young adults with Multiple Sclerosis)
Education Program to Improve Self-Management in Newly Diagnosed Individuals with Multiple Sclerosis
Partnerships & Referral Network
- MedStar Georgetown University Hospital
- Georgetown University
- Georgetown Lombardi Arts and Humanities Program (Movement for MS)
Services & Treatments
What They Treat
multiple sclerosisneuromyelitis opticavasculitismyasthenia gravisneuro-sarcoidosisSjogren’s diseasestiff person syndromeparaneoplastic syndromesoptic neuritistransverse myelitisvision loss due to neurologic diseasesidiopathic intracranial hypertensionischemic optic neuropathygiant cell arteritis
How They Treat It
Diagnosis and treatment of multiple sclerosisDiagnosis and treatment of neuroimmunology disordersSpasticity evaluation and treatmentBotulinum toxin injectionsIntrathecal baclofen pump evaluation and screeningIntrathecal baclofen pump refillsCoordination of pump-related surgical or radiological interventionsNeuromyelitis optica (NMO) diagnosis and treatmentNeuro-ophthalmology evaluation and treatmentVisual field perimetryOptical coherence tomography (OCT)Fundus photographyPatient education eventsEducational videosCommunity outreach seminarsoral anti-spasmodic agentsbotulinum toxin injectionintrathecal baclofen pumpdisease modifying therapies
Diagnostics
visual field perimetryoptical coherence tomography (OCT)fundus photographyscreening tests for intrathecal baclofen pump placement
Research & Clinical Trials
This center is currently involved in 11 clinical trials — ranked #1 in District of Columbia for active trials
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabPlacebo
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
ACTIVE NOT RECRUITINGPHASE3
TolebrutinibPlaceboTeriflunomide
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals Inc.
RECRUITINGPHASE1
AMX0114Placebo
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
RECRUITINGPHASE1
Biospecimen CollectionNivolumab
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)
RECRUITINGPHASE4
OcrelizumabPlacebo for Ocrelizumab
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
ACTIVE NOT RECRUITINGNA
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod
Insurance & Access
Contact
MedStar Georgetown University Hospital, 3800 Reservoir Road NW, 7 PHC, Washington, DC 20007-2197
Insurance & Support
Related MS Research
Recent studies relevant to this center's focus areas
FAQs from Georgetown Multiple Sclerosis and Neuroimmunology Center
The center treats multiple sclerosis and a range of neuroimmunology conditions, including neuromyelitis optica, vasculitis, myasthenia gravis, neuro-sarcoidosis, Sjogren’s disease, optic neuritis, and transverse myelitis. It also evaluates vision loss related to neurologic disease and other complex neurologic inflammatory conditions.
Yes. The team offers dedicated clinics for spasticity, neuromyelitis optica, and neuro-ophthalmology. That can be helpful if you need care for a specific symptom or condition tied to MS or another neuroimmunology disorder.
The center offers visual field perimetry, optical coherence tomography (OCT), and fundus photography. It also provides screening tests for intrathecal baclofen pump placement.
Spasticity care includes evaluation and treatment, oral anti-spasmodic agents, botulinum toxin injections, and intrathecal baclofen pump evaluation, refills, and coordination of related procedures. The center also works with surgical or radiological interventions when needed.
You can call (202) 444-8525 to schedule. The center is based in Washington, DC and is part of Georgetown University and MedStar Georgetown University Hospital.
Compare District of Columbia MS Centers
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Georgetown Multiple Sclerosis and Neuroimmunology Center Washington | Academic MS Center | — | — | 3.2/5 |
MedStar Washington Hospital Center Washington | Community Hospital Program | — | — | 3.4/5 |
Georgetown Multiple Sclerosis and Neuroimmunology Center
Washington • Academic MS Center
Infusion
—
Virtual
—
Experience
3.2/5
MedStar Washington Hospital Center
Washington • Community Hospital Program
Infusion
—
Virtual
—
Experience
3.4/5
MS Centers Across the U.S.
Click a state to browse its MS treatment centers.
Check out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.